SCOPUS 정보 검색 플랫폼

British Medical Journal

Volumn 323, Issue 7322, 2001, Pages 1141-1142

Treatment of chronic hepatitis C

(1) Davis, G L a

a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MACROGOL; RIBAVIRIN;

ANTIVIRAL ACTIVITY; CHRONIC HEPATITIS; DRUG EFFICACY; DRUG MIXTURE; EDITORIAL; ERADICATION THERAPY; HEPATITIS C; HUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0035904615 PISSN: 09598146 EISSN: None Source Type: Journal
DOI: 10.1136/bmj.323.7322.1141 Document Type: Editorial

Times cited : (24)

References (13)

1
- 0029833829
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
- (1996) Hepatology , vol.24 , pp. 778-789
- Poynard, T.¹ Leroy, V.² Cohard, M.³ Thevenot, T.⁴ Mathurin, P.⁵ Opolon, P.⁶

2
- 0032547938
- Interferon alfa-2b montherapy versus interferon alfa-2b plus ribavirin as initial treatment for chronic hepatitis C: Results of a US multicenter randomized controlled study
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶

3
- 0032585237
- Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.³ Niederau, C.⁴ Minuk, C.S.⁵ Ideo, G.⁶

4
- 0035904617
- Interferon alfa with or without ribavirin for interferon naive patients, relapsers, and non-responders with chronic hepatitis C: Systematic review of randomised trials
- (2001) BMJ , vol.323 , pp. 1151-1155
- Kjaergard, L.L.¹ Krogsgaard, K.² Gluud, C.³

5
- 0033965268
- Current therapy for chronic hepatitis C
- (2000) Gastroenterology , vol.118
- Davis, G.L.¹

6
- 0034619946
- Peginterferon alfa-2a in patients with chronic hepatitis C
- (2000) N Engl J Med , vol.343 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, S.V.² Rasenack, J.³ Heathcote, E.J.⁴ Lai, M.Y.⁵ Gane, E.⁶

7
- 17844403232
- A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
- (2001) Hepatology , vol.34 , pp. 395-403
- Lindsay, K.L.¹ Trepo, C.² Heintges, T.³ Shiffman, M.L.⁴ Gordon, S.C.⁵ Hoefs, J.C.⁶

8
- 0000155914
- PEG interferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial
- (2000) Hepatology , vol.32
- Manns, M.P.¹ McHutchison, J.G.² Gordon, S.³ Rustgi, V.⁴ Shiffman, M.L.⁵ Lee, W.M.⁶

9
- 0000268538
- Pegylated interferon alfa-2a in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively controlled, multicenter study
- (2001) Gastroenterology , vol.120
- Fried, M.W.¹ Shiffman, M.L.² Reddy, R.K.³ Smith, C.⁴ Marino, G.⁵ Goncales, F.⁶

10
- 0027972001
- Long-term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferon
- (1994) Liver , vol.14 , pp. 302-307
- Marcellin, P.¹ Boyer, N.² Degott, C.³ Martinot-Peignoux, M.⁴ Duchatelle, V.⁵ Giostra, E.⁶

11
- 0033766167
- Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C
- (2000) Hepatology , vol.32 , pp. 1131-1137
- Poynard, T.¹ McHutchison, J.² Davis, G.L.³ Esteban Mur, R.⁴ Goodman, Z.⁵ Bedossa, P.⁶

12
- 0000707195
- Projecting the future healthcare burden from hepatitis C in the United States
- (1998) Hepatology , vol.28
- Davis, G.L.¹ Albright, J.E.² Cook, S.F.³ Rosenberg, D.M.⁴

13
- 0033799722
- Estimating future hepatitis C morbidity, mortality, and costs in the United States
- (2000) Am J Public Health , vol.90 , pp. 1562-1569
- Wong, J.B.¹ McQuillan, G.M.² McHutchison, J.G.³ Poynard, T.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.